Development of a Clinical Photographic Atlas for Skin Aging Based on the Characterization of Faci… (NCT07409675) | Clinical Trial Compass
CompletedNot Applicable
Development of a Clinical Photographic Atlas for Skin Aging Based on the Characterization of Facial Dermal Collagen Using LC-OCT Technology
France250 participantsStarted 2024-11-06
Plain-language summary
This is a single-center, single visit study conducted in healthy female subjects, aged 20 to 75 years inclusive meeting specific inclusion/exclusion criteria. The study is to develop a clinical photographic atlas to assess skin aging by studying the relationship between age, sun exposure and quantity of collagen measured non-invasively (LC-OCT). No product will be tested during the study.
Who can participate
Age range20 Years – 75 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject having signed an Informed Consent Form (ICF) before any trial related activity is carried out;
* Healthy female subject aged 20 to 75 years inclusive at the time of signing the ICF;
* Subject with a phototype I to III on Fitzpatrick's scale;
* Subject who is willing to follow the study procedures and to complete the study course;
* Subject registered with Social Security in agreement with French law on study research.
Exclusion Criteria:
* Male subject;
* Female subject who is pregnant or who is breast feeding;
* Subject with current participation in any other interventional clinical study, based on interview of the subject;
* Subject with facial dermatitis, rosacea, acne, eczema, psoriasis, skin rashes, open lesions, vitiligo or viral conditions such as herpes labialis;
* Subject who has collagen vascular disease, a significant systemic disease, immunological problems or inflammatory skin conditions on the face;
* Subject who has had a face lift;
* Subject has had a non-ablative and/or ablative laser procedure on the face in the past 3 months;
* Subject with a history of botulinum toxin or mesotherapy injections on the face within the last 6 months, or absorbable fillers injections (such as hyaluronic acid or autologous fat…) in the last 12 months or injectable implants (semi-permanent fillers) within the last 24 months;
* Subject having done a moderate to deep peeling or non-invasive rejuvenation techniques such as radiofrequency, ultrasound…
What they're measuring
1
Non-invasive tissue imaging: 3D imaging through Line-field Confocal Optical Coherence Tomography technology (LC-OCT) acquisitions